Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Golidocitinib |
| Trade Name | |
| Synonyms | AZD 4205|AZD-4205|AZD4205 |
| Drug Descriptions |
Golidocitinib (AZD4205) is a selective inhibitor of JAK1, which reduces downstream signaling and may lead to inhibition of cell proliferation and tumor growth (PMID: 32297743, NCI Thesaurus). |
| DrugClasses | JAK1 Inhibitor 9 |
| CAS Registry Number | 2091134-68-6 |
| NCIT ID | C156774 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Cyclophosphamide + Doxorubicin + Golidocitinib + Prednisone + Vincristine Sulfate | Cyclophosphamide Doxorubicin Golidocitinib Prednisone Vincristine Sulfate | 0 | 1 |
| Golidocitinib | Golidocitinib | 0 | 1 |
| Golidocitinib + Osimertinib | Golidocitinib Osimertinib | 0 | 0 |